0001437749-19-006476.txt : 20190403 0001437749-19-006476.hdr.sgml : 20190403 20190403163025 ACCESSION NUMBER: 0001437749-19-006476 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linn Stefan C CENTRAL INDEX KEY: 0001604050 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 19729385 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL STREET 2: 940 INNOVATION DRIVE CITY: MILTON PARK ABINGDON STATE: X0 ZIP: OX14 4RZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2019-04-01 0001586049 Oxford Immunotec Global PLC OXFD 0001604050 Linn Stefan C C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 Chief Operating Officer Ordinary Shares 2019-04-01 4 A 0 20901 0 A 59066 D Share Option (Right to Buy) 16.42 2019-04-01 4 A 0 44853 0 A 2029-04-01 Ordinary Shares 44853 44853 D Options granted under Issuer's 2013 Share Incentive Plan. Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2020 through January 1, 2023. /s/ Elizabeth M. Keiley, as Attorney-in-Fact 2019-04-03